Peptide-Drug Conjugate: A Novel Drug Design Approach.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Peptide-Drug Conjugate: A Novel Drug Design Approach.
- Published In:
- Current medicinal chemistry, 24(31), 3373-3396 (2017)
- Authors:
- Ma, Liang, Wang, Chao(3), He, Zihao, Cheng, Biao, Zheng, Ling, Huang, Kun
- Database ID:
- RPEP-03383
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-03383APA
Ma, Liang; Wang, Chao; He, Zihao; Cheng, Biao; Zheng, Ling; Huang, Kun. (2017). Peptide-Drug Conjugate: A Novel Drug Design Approach.. Current medicinal chemistry, 24(31), 3373-3396. https://doi.org/10.2174/0929867324666170404142840
MLA
Ma, Liang, et al. "Peptide-Drug Conjugate: A Novel Drug Design Approach.." Current medicinal chemistry, 2017. https://doi.org/10.2174/0929867324666170404142840
RethinkPeptides
RethinkPeptides Research Database. "Peptide-Drug Conjugate: A Novel Drug Design Approach." RPEP-03383. Retrieved from https://rethinkpeptides.com/research/ma-2017-peptidedrug-conjugate-a-novel
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.